News
17mon MSN
Eli Lilly said the response for its blockbuster drug Mounjaro has been "positive" in India, adding that it is focusing on ...
EULAR now recommends moving directly to biologic or targeted synthetic disease-modifying antirheumatic drugs if the initial ...
A large, multicountry European study finds that adults with type 2 diabetes who start empagliflozin experience no increased ...
21h
Pharmaceutical Technology on MSNEli Lilly and Eisai’s Alzheimer’s drugs denied NHS use due to high costsNICE said it made every effort to support reimbursement for Kisunla and Leqembi, but found the medicines are “not good value ...
GLP-1 drugs are revolutionizing the treatment of obesity and diabetes. Here's what to know about investing in GLP-1 stocks.
18h
Zacks Investment Research on MSNWhat is the Intent Behind Eli Lilly's Recent M&A Deals Spree?Eli Lilly LLY signed a definitive agreement to acquire Verve Therapeutics VERV for a total deal value of nearly $1.3 billion.
Israelis lack sleep and experience high anxiety amid the wars with Hamas and Iran as the two Middle East nations exchange ...
Oprah Winfrey and Elon Musk endorsed it. And though Indian celebrities haven’t yet admitted to their use, the mystery ...
Drinking a cup or two of coffee every day may help you live longer -- but only if you skip the heavy cream and sugar, new ...
The UK's state-run health service said Thursday it will not offer two new treatments for Alzheimer's disease, citing high ...
Lilly Collaboration Accelerates RyboDyn's Dark Proteome Targets Toward First-in-Class Therapies SAN DIEGO, /PRNewswire/ -- RyboDyn, Inc., a biotechnology company pioneering first-in-class ...
Mounjaro will soon be available on the NHS across the UK but it's important patients avoid the dangerous 'golden dose' trend ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results